Author Archives: Sarah Roden

Analysts Assess Wells Fargo & Co (WFC) Amid Account Scandal

Shaking hands

Just as banks are beginning to regain public trust as the country recovers from the 2008 financial crisis, recent headlines surrounding Wells Fargo & Co (NYSE:WFC) may compromise that progress. Wells Fargo, one of the biggest banks in the world,

Analysts Remain Wary on Twitter Inc (TWTR) Despite Buyout Rumors


By many standards, a website that boasts over 300 million monthly active users and quarterly revenue of over $600 million (as reported in the second quarter of 2016) is no small feat. However, in the shadow of tech giants like

Brean Capital Touts Little-Known Biotech Company, Akebia Therapeutics Inc (AKBA)

Akebia logo

Akebia Therapeutics Inc (NASDAQ:AKBA), the clinical development stage biotechnology company based in Boston, does not have any approved therapies, yet it is best known for its efforts to use HIF, or hypoxia inducible factor, to treat serious diseases by harnessing the power of

Analyst Estimates on Apple Inc. (AAPL) Following iPhone 7 Sales Expectations

Apple logo

Shares of Apple Inc. (NASDAQ:AAPL) have risen more than 4% since the technology giant released the iPhone 7 on September 7. The new model made waves by eliminating the need for a headphone jack. While this is convenient for those

Canaccord Genuity Weighs in on Sequential Brands Group Inc (SQBG) in Light of First Investor Day

Sequential Brands logo

Following the first investor day for Sequential Brands Group Inc (NASDAQ:SQBG), Camilo Lyon of Canaccord Genuity weighs in on the company. Lyon is quick to point out the exponential growth experienced by Sequential Brands recently. The company expects approximately $161

Susquehanna Analyst Updates PepsiCo, Inc. (PEP) Estimates Ahead of Earnings

Pepsi logo

PepsiCo, Inc. (NYSE:PEP) will release third quarter earnings tomorrow before market open. Ahead of the release, Pablo Zuanic of Susquehanna weighs in on the company, adjusting his earnings estimate and sharing his expectations for the report. Zuanic has slightly raised